Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891

https://doi.org/10.1016/0014-2999(90)94091-BGet rights and content

Abstract

Potassium channel activators have been shown to protect ischemic myocardium. We studied the ability of the novel potassium channel activator, RP 52891, to also reduce ischemic damage in isolated globally ischemic rat hearts. RP 52891 (1–100 μM) was given before the hearts were subjected to 25 nun of ischemia and 30 min of reperfusion. Before ischemia, RP 52891 reduced contractile function only at the highest concentration (100 μM). Significant reductions in ischemie damage were observed at 3 μM and higher concentrations. RP 52891 improved reperfusion contractile function and reduced lactate dehydrogenase release. Contracture was significantly reduced by RP 52891 during reperfusion. The protective effects of RP 52891 were completely reversed by glyburide and sodium 5-hydroxyde-canoate, both Mockers of ATP-sensitive potassium channels. Thus, RP 52891 has direct cardioprotective efficacy, which may be related to activation of ATP-sensitive potassium channels.

References (25)

  • W.M. Vogel et al.

    Post-ischemic cardiac chamber stiffness and coronary vasomotion: The role of edema and effects of dextran

    J. Mol. Cell Cardiol.

    (1986)
  • J.A. Watts et al.

    Effects of diltiazem upon globally ischemic rat hearts, European

    J. Pharmacol.

    (1987)
  • C.R. Cain et al.

    Electrophysiological effects of the antihyperlensive agent BRL 34915 in guinea pig papillary muscle, Naunyn-Schmiedeb

    Arch. Pharmacol.

    (1985)
  • M.S. Cook et al.

    Similarities in the mechanism of action of two new vasodilator drugs pinacidil and BRL 34915

    J. Cardiovasc. Pharmacol.

    (1988)
  • D. Escande et al.

    Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea pig cardiac myocytes

    Pflügers Arch.

    (1989)
  • M. Fossett et al.

    Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels

    J. Biol. Chem.

    (1988)
  • G.J. Grover et al.

    Anti-ischemie effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide

    J. Pharmacol. Exp. Ther.

    (1989)
  • G.J. Grover et al.

    Anti-ischemic and antifibrillatory effects of the K+ channel activaiors cromakalim and pinacidil in dog and isolated rat hearts

    Circulation

    (1989)
  • G.J. Grover et al.

    Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocadium with a lower functional cost as compared with verapamil or nifedipine

    J. Cardiovasc. Pharmacol.

    (1989)
  • T.C. Hamilton et al.

    Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein

    Br. J. Pharmacol.

    (1986)
  • C.W. Hamm et al.

    Protective effects of verapamil, nifedipine and diltiazem in the coronary-ligated, isolated working rat heart

    Circ. Res.

    (1983)
  • S. Imanishi et al.

    Effects of SG-75 (nicorandil) on electrical activity of canine cardiac purkinje: Possible increase in potassium conductance

    J. Pharmacol. Exp. Ther.

    (1983)
  • Cited by (74)

    • The Discovery of Myocardial Preconditioning Using Volatile Anesthetics: A History and Contemporary Clinical Perspective

      2018, Journal of Cardiothoracic and Vascular Anesthesia
      Citation Excerpt :

      In a remarkably productive display of scientific creativity during the following 3 years,149 Gross published a series of articles in rapid succession that further defined the KATP channel-dependence of IPC150–152 and myocardial stunning131 and demonstrated that G protein-linked receptor ligands, including acetylcholine (through the muscarinic type 2 receptor),153,154 adenosine (A1 receptor),155,156 and opioids (delta type 1 receptor),157,158 mimicked these phenomena through their actions on KATP channels.159 These latter investigations firmly established the concept of “pharmacological preconditioning” suggested earlier by Grover140–142 and Downey.137 From the perspective of the current discussion, it is notable that Warltier was a university colleague and frequent collaborator with Gross; the 2 researchers published more than 80 articles together through 1993,ǁ including 2 that described the role of KATP channels in myocardial ischemic injury.160,161

    • Mitochondrial potassium transport: The role of the mitochondrial ATP-sensitive K<sup>+</sup> channel in cardiac function and cardioprotection

      2003, Biochimica et Biophysica Acta - Bioenergetics
      Citation Excerpt :

      Grover et al. [19] were the first to evaluate KCOs for their ability to protect the heart against ischemia–reperfusion injury. They found cromakalim and pinacidil to be protective in the perfused rat heart model [19], and subsequently showed that other KCOs, including bimakalim, aprikalim, and P-1075, also protected isolated rat hearts [28–30]. Investigators have demonstrated cardioprotection by KCOs in isolated hearts from rats, rabbits, ferrets, and guinea pigs [31–36].

    View all citing articles on Scopus
    View full text